银诺医药-B(02591.HK):香港公开发售获5341.66倍认购

智通财经
Aug 14
【银诺医药-B(02591.HK):香港公开发售获5341.66倍认购】智通财经APP讯,银诺医药-B(02591.HK)公布配发结果,公司全球发售3655.64万股股份,香港公开发售占10%,国际发售占90%。最终发售价每股18.68港元,全球发售净筹约6.35亿港元。每手200股,预期H股将于2025年8月15日(星期五)上午九时正在联交所开始买卖。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10